表紙
市場調査レポート

在宅医療の米国市場の将来展望 (2020年まで)

US Home Healthcare Market Outlook 2020

発行 RNCOS E-Services Pvt. Ltd. 商品コード 329053
出版日 ページ情報 英文 70 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
在宅医療の米国市場の将来展望 (2020年まで) US Home Healthcare Market Outlook 2020
出版日: 2015年04月01日 ページ情報: 英文 70 Pages
概要

米国の在宅医療産業は、最も急速な成長を遂げている分野の一つです。高齢者人口の増加や政府の支援策、高額な入院治療から自宅治療への移行、慢性疾患患者の増加、在宅治療に対する医師側の受容の広がり、技術進歩、公的・民間保険によるコスト効率的な治療オプションの提供、といった数々の要因が業界の成長を促進しています。米国の在宅医療市場は2015〜2020年にかけて、約7%の年平均成長率 (CAGR) で成長する見通しです。

当レポートでは、米国の在宅医療市場について分析し、業界の最新動向や主な成長促進要因、政府の規制・支援体制、将来の市場動向見通し (今後6年間分)、分野別の詳細動向 (医療機器/サービス/遠隔治療)、主要企業のプロファイルといった情報を取りまとめてお届けいたします。

第1章 アナリストの見解

第2章 分析手法

第3章 市場の動向と促進要因

  • 技術進歩により、医療機器が在宅医療でも使用可能なオプションとなる
  • 人口高齢化による在宅医療の普及
  • 各種疾患の有病者数の増加に伴う、自宅での治療・モニタリング需要の拡大

第4章 在宅医療市場の将来展望 (2020年まで)

  • 装置別
    • 診断・モニタリング用装置
    • 治療用装置
    • 医療用品
    • 移動支援装置
  • サービス別
    • 非熟練介護サービス
    • リハビリ療法サービス
    • 呼吸療法サービス
    • 点滴療法サービス
  • 遠隔治療 (テレヘルス)

第5章 規制体制

第6章 競合環境

  • Lincare Holdings Inc.
    • 事業概要
    • 主な財務指標
    • 競争上の強み・弱みの分析
  • Kindred Healthcare Inc.
  • Amedisys, Inc.
  • Apria Health Group
  • Chemed Corporation
  • National HealthCare Corporation
  • LHC Group, Inc.

図表一覧

目次

US home healthcare industry has become one of the fastest growing sectors. An increasing number of aging population and government initiatives, shifted the expensive hospital care to the home. The prevalence of chronic diseases, growing physician acceptance of home healthcare, technological advancements and cost-effective treatment options from public and private payers have all fostered the industry growth. The home healthcare market is forecasted to grow at a CAGR of approximately 7% during 2015-2020.

In latest research study, "US Home Healthcare Market Outlook 2020", RNCOS' analysts have identified the market dynamics and clearly highlight the areas offering promising possibilities for companies to boost their growth. The growth of the market is driven by increasing federal and state funding by Medicare and Medicaid boosting the demand for healthcare services.

In the present report, the market has been studied on three major grounds - by services (unskilled nursing service, rehabilitation therapy, infusion therapy, respiratory therapy), by equipment (diagnostic and monitoring home devices, medical supplies, therapeutic home healthcare, mobility assist devices) and by telehealth. Further, the growth of all the segments have been analyzed with market projections till 2020.

The study also includes current market trends and drivers detailing the growth and the untapped potential of the market. Moreover, it delves into the present regulatory framework related to the industry. The report additionally provides an insight about the competitive landscape, which includes business overview, key financials and strengths and weaknesses of the top home healthcare players in the US. There's also coverage of the detailed analysis of their top services in terms of revenue generation.

This report would help the clients to identify the driving force and opportunities existing in the market. In a nutshell, the research provides all the prerequisite information for intending clients looking out to venture in US home healthcare industry, and facilitate them to devise strategies while going for an investment/partnership in the market.

Table of Contents

1. Analyst View

2. Research Methodology

3. Market Trends and Drivers

  • 3.1 Technological Advancement Making Medical Devices a Viable Option for Home Healthcare
  • 3.2 Aging Population Driving the Adoption of Home Healthcare
  • 3.3 Rising Prevalence of Diseases Boosting the Demand for Therapy and Monitoring at Home

4. Home Healthcare Market Outlook to 2020

  • 4.1 By Equipment
    • 4.1.1 Diagnostic & Monitoring Devices
    • 4.1.2 Therapeutics Devices
    • 4.1.3 Medical Supplies
    • 4.1.4 Mobility Assist Devices
  • 4.2 By Services
    • 4.2.1 Unskilled Nursing Services
    • 4.2.2 Rehabilitation Therapy Services
    • 4.2.3 Respiratory Therapy Services
    • 4.2.4 Infusion Therapy Services
  • 4.3 Telehealth

5. Regulatory Framework

6. Competitive Landscape

  • 6.1 Lincare Holdings Inc.
    • 6.1.1 Business Overview
    • 6.1.2 Key Financials
    • 6.1.3 Strength and Weakness Analysis
  • 6.2 Kindred Healthcare Inc.
    • 6.2.1 Business Overview
    • 6.2.2 Key Financials
    • 6.2.3 Strength and Weakness Analysis
  • 6.3 Amedisys, Inc.
    • 6.3.1 Business Overview
    • 6.3.2 Key Financials
    • 6.3.3 Strength and Weakness Analysis
  • 6.4 Apria Health Group
    • 6.4.1 Business Overview
    • 6.4.2 Key Financials
    • 6.4.3 Strength and Weakness Analysis:
  • 6.5 Chemed Corporation
    • 6.5.1 Business Overview
    • 6.5.2 Key Financials
    • 6.5.3 Strength and Weakness Analysis
  • 6.6 National HealthCare Corporation
    • 6.6.1 Business Overview
    • 6.6.2 Key Financials
    • 6.6.3 Strength and Weakness Analysis
  • 6.7 LHC Group, Inc.
    • 6.7.1 Business Overview
    • 6.7.2 Key Financials
    • 6.7.3 Strength and Weakness Analysis

List of Figures:

  • Figure 3-1: Per Day Cost (US$) - Hospital Vs Home or Alternate Site
  • Figure 4-1: Home Healthcare Market (Billion US$), 2014-2020
  • Figure 4-2: Home Healthcare Market by Segment (%), 2014
  • Figure 4-3: Home Healthcare Market by Player (%), 2014
  • Figure 4-4: Home Healthcare Market by Payor (%), 2012
  • Figure 4-5: Home Healthcare Equipment Market (Billion US$), 2014-2020
  • Figure 4-6: Home Healthcare Equipment Market by Type (%), 2014
  • Figure 4-7: Diagnostics and Monitoring Home Devices Market (Billion US$), 2014 & 2020
  • Figure 4-8: Therapeutics Home Devices Market (Billion US$), 2014 & 2020
  • Figure 4-9: Medical Supplies Market (Billion US$), 2014 & 2020
  • Figure 4-10: Mobility Assist Devices Market (Billion US$), 2014 & 2020
  • Figure 4-11: Home Healthcare Services Market (Billion US$), 2014-2020
  • Figure 4-12: Home Healthcare Services Market by Type (%), 2014
  • Figure 4-13: Unskilled Nursing Services Market (Billion US$), 2014 & 2020
  • Figure 4-14: Rehabilitation Therapy Services Market (Billion US$), 2014 & 2020
  • Figure 4-15: Respiratory Therapy Services Market (Billion US$), 2014 & 2020
  • Figure 4-16: Infusion Therapy Services Market (Billion US$), 2014 & 2020
  • Figure 4-17: Telehealth Market (Billion US$), 2014-2020
  • Figure 6-1: Lincare Holdings Inc. - Revenue by Segment (%), 2011
  • Figure 6-2: Lincare Holdings Inc. - Revenue by Payors (%), 2011
  • Figure 6-3: Kindred Healthcare Inc. - Revenue by Segment (%), 2014
  • Figure 6-4: Kindred Healthcare Inc- Care Management Revenue by Services (%), 2014
  • Figure 6-5: Kindred Healthcare Inc - Care Management Revenue by Payors (%), 2014
  • Figure 6-6: Amedisys, Inc - Revenue by Services (%), 2013
  • Figure 6-7: Amedisys, Inc - Revenue by Payors (%), 2013
  • Figure 6-8: Apria Health Group - Revenue by Services (%), 2012
  • Figure 6-9: Chemed Corporation - Revenue by Subsidiaries (%), 2013
  • Figure 6-10: Chemed Corporation (Subsidiary Vitas Healthcare Corporation) - Revenue by Services (%), 2013
  • Figure 6-11: Chemed Corporation (Subsidiary-Vitas Healthcare Corporation) - Revenue by Payors (%), 2013
  • Figure 6-12: National Healthcare Corporation - Revenue by Payors (%), 2013
  • Figure 6-13: LHC Group Inc. - Revenue by Segments (%), 2013
  • Figure 6-14: LHC Group Inc. - Revenue by Payors (%), 2013

List of Tables:

  • Table 4-1: Leading Manufacturers of Home Diagnostic and Monitoring devices
  • Table 4-2: Leading Manufacturers of Therapeutic Home Healthcare Devices
  • Table 4-3: Leading Manufacturers of Medical Supplies
  • Table 4-4: Leading Manufacturers of Mobility Assist Devices
  • Table 4-5: Leading Manufacturers of Home Infusion Devices
  • Table 6-1: Home Healthcare Market Penetration by Players
  • Table 6-2: Lincare Holdings Inc. - Financial Overview (Million US$), FY 2009-FY 2011
  • Table 6-3: Kindred Healthcare Inc. - Financial Overview (Million US$), FY 2012-FY 2014
  • Table 6-4: Amedisys, Inc - Financial Overview (Million US$), FY 2011-FY 2013
  • Table 6-5: Apria Health Group - Financial Overview (Million US$), FY 2010-FY 2012
  • Table 6-6: Chemed Corporation - Financial Overview (Million US$), FY 2011-FY 2013
  • Table 6-7: National Healthcare Corporation - Financial Overview (Million US$), FY 2011-FY 2013
  • Table 6-8: LHC Group Inc. - Financial Overview (Million US$), FY 2011-FY 2013
Back to Top